Splenomegaly

• 

  Subject Areas on Research

  • 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice. 
  • 74-Year-Old Woman With Fatigue, Anorexia, and Abdominal Pain. 
  • A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. 
  • A fatal x-linked recessive reticuloendothelial syndrome with hyperglobulinemia. X-linked recessive reticuloendotheliosis. 
  • A pattern-oriented approach to splenic imaging in infants and children. 
  • A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. 
  • ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder. 
  • An inherited disorder with splenomegaly, cytopenias, and vision loss. 
  • Argatroban for anticoagulation during cardiopulmonary bypass in an infant. 
  • Autoimmune lymphoproliferative syndrome: an update and review of the literature. 
  • Bacillary angiomatosis of the conjunctiva. 
  • Case report: splenic infarction and acute splenic sequestration in adults with hemoglobin SC disease. 
  • Cellular FLIP Inhibits Myeloid Cell Activation by Suppressing Selective Innate Signaling. 
  • Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. 
  • Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. 
  • Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly. 
  • Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies. 
  • Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. 
  • Does this patient have malaria? 
  • Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. 
  • Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. 
  • Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958-1970. 
  • Gigantic splenomegaly in a 27-year-old male of South-East Asian descent with concurrent diagnosis of myeloproliferative neoplasm and hemoglobin H disease. 
  • Glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice. 
  • Hairy cell leukemia: an elusive but treatable disease. 
  • Heterogeneous splenic enhancement patterns on spiral CT images in children: minimizing misinterpretation. 
  • Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms. 
  • Inducers of Friend leukaemic cell differentiation in vitro--effects of in vivo administration. 
  • Inherited lipemic splenomegaly and the spectrum of apolipoprotein E p.Leu167del mutation phenotypic variation. 
  • Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial. 
  • Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. 
  • Lymphocyte accumulation in the spleen of retinoic acid receptor-related orphan receptor gamma-deficient mice. 
  • Ophthalmic Manifestations of ROSAH (Retinal Dystrophy, Optic Nerve Edema, Splenomegaly, Anhidrosis, and Headache) Syndrome, an Inherited NF κB-Mediated Autoinflammatory Disease with Retinal Dystrophy. 
  • Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. 
  • Partial splenectomy for children with congenital hemolytic anemia and massive splenomegaly. 
  • Persistence of portosystemic collaterals and splenomegaly on CT after orthotopic liver transplantation. 
  • Persistent thrombocytopaenia in a young man with splenomegaly, rebound thrombocytosis after splenectomy and subsequent pulmonary embolism: splenic littoral cell angioma and associated events. 
  • Prednisone-responsive aplastic anemia associated with T-lymphocyte proliferation. 
  • Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. 
  • Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. 
  • Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias. 
  • Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. 
  • Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonlymphoblastic leukemia. 
  • Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni. 
  • Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. 
  • Splenectomy in sickle-cell disease. 
  • The Importance of IL-6 in the Development of LAT-Mediated Autoimmunity. 
  • The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission. 
  • Xist RNA is a potent suppressor of hematologic cancer in mice.